Riddhi Siddhi Gluco Biols Intrinsic Value
Riddhi Siddhi Gluco Biols (RIDDHI) median intrinsic value is ₹754.29 from 8 valuation models (range ₹247–₹1984), vs current price ₹673.05 — +12.1% upside (Trading Below Median Value), margin of safety 10.8%. Also explore Riddhi Siddhi Gluco Biols stock price data download to track price trends across different timeframes.
RIDDHI Valuation Methods Summary — DCF, Graham Number & P/E
Riddhi Siddhi Gluco Biols intrinsic value across 8 models vs current price ₹673.05 — upside/downside and value range per method. Browse RIDDHI income statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹926.40 | ₹741.12 - ₹1111.68 | +37.6% | EPS: ₹77.20, Sector P/E: 12x |
| Book Value Method | asset | ₹1682.62 | ₹1514.36 - ₹1850.88 | +150.0% | Book Value/Share: ₹2267.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹246.86 | ₹222.17 - ₹271.55 | -63.3% | Revenue/Share: ₹308.57, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹754.29 | ₹678.86 - ₹829.72 | +12.1% | EBITDA: ₹88.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹269.22 | ₹215.38 - ₹323.06 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹494.08 | ₹444.67 - ₹543.49 | -26.6% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹636.13 | ₹572.52 - ₹699.74 | -5.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹1984.45 | ₹1786.01 - ₹2182.90 | +194.8% | EPS: ₹77.20, BVPS: ₹2267.14 |
RIDDHI Intrinsic Value vs Market Price — All Valuation Models
Riddhi Siddhi Gluco Biols fair value range ₹247–₹1984 vs current market price ₹673.05 across 8 valuation models. For current market price and key ratios, visit Riddhi Siddhi Gluco Biols share price today.
RIDDHI Intrinsic Value Analysis — Undervalued or Overvalued?
Riddhi Siddhi Gluco Biols median intrinsic value ₹754.29, current price ₹673.05 — Trading Below Median Value by 12.1%, margin of safety 10.8%.
What is the intrinsic value of RIDDHI?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Riddhi Siddhi Gluco Biols (RIDDHI) is ₹754.29 (median value). With the current market price of ₹673.05, this represents a +12.1% variance from our estimated fair value.
The valuation range spans from ₹246.86 to ₹1984.45, indicating ₹246.86 - ₹1984.45.
Is RIDDHI undervalued or overvalued?
Based on our multi-method analysis, Riddhi Siddhi Gluco Biols (RIDDHI) appears to be trading below median value by approximately 12.1%.
RIDDHI Financial Health — Key Ratios vs Industry Benchmarks
Riddhi Siddhi Gluco Biols financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 38.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.12x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
RIDDHI Cash Flow Quality — Operating & Free Cash Flow
Riddhi Siddhi Gluco Biols operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-28 Cr | ₹-28 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹161 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹130 Cr | ₹104 Cr | Positive Free Cash Flow | 8/10 |